A study of anthropometric parameters in children with beta thalassemia major
DOI:
https://doi.org/10.18203/2349-3291.ijcp20261901Keywords:
Anthropometric parameters, Beta thalssemia major, Children, OutcomeAbstract
Background: Growth failure is a common and persistent complication in children with beta thalassemia major despite advances in regular blood transfusion, bone marrow transplantation and supportive care, which have improved survival.
Methods: This cross-sectional study was conducted among 100 children with beta thalassemia major attending the pediatric outpatient department or admitted to a tertiary care center in Surat. Anthropometric measurements were recorded and correlated with serum ferritin levels.
Results: The majority of children were aged 6–10 years (47%), followed by 1–5 years (39%), while 1% were below 1 year. Boys constituted 60% of the study population. Among children with hemoglobin <8 g/dl, 58.62% had serum ferritin >2000 μg/l, while 69.23% of those with Hb ≥8 g/dl also had ferritin >2000 μg/L. The mean weight, height and BMI were 17.9 kg, 109 cm and 15.02 kg/m², respectively. Nearly one-third of children had weight below the 3rd centile and about one-fifth were between the 3rd and 10th centiles.
Conclusions: Growth impairment remains highly prevalent among children with beta thalassemia major, with significant stunting and underweight. Most children were aged 6–10 years and predominantly male. Nearly half were stunted. While weight centiles showed no significant association with serum ferritin levels, height and BMI centiles demonstrated significant correlation, indicating a greater impact of iron overload on linear growth.
References
Brittenham GM. Iron-chelating therapy for transfusional iron overload. N Engl J Med. 2011;364(2):146-56.
Olivieri NF, Brittenham GM. Iron-chelating therapy and the treatment of thalassemia. Blood J American Soc Hematol. 1997;89(3):739-61.
Grundy RG, Woods KA, Savage MO, Evans JP. Relationship of endocrinopathy to iron chelation status in young patients with thalassaemia major. Arch Dis Child. 1994;71(2):128-32.
Hashemi A, Ghilian R, Golestan M, Akhavan Ghalibaf M, Zare Z, Dehghani MA. The study of growth in thalessemic patients and its correlation with serum ferritin level. Iranian J Pediat Hematol Oncol. 2021;1:3984.
Bronspiegel-Weintrob N, Olivieri NF, Tyler B, Andrews DF, Freedman MH, Holland FJ. Effect of age at the start of iron chelation therapy on gonadal function in beta-Thalassemia major. N Engl J Med. 1990;13(11):713-9.
Badiger S, Baruah A. A study of growth pattern in regularly transfused thalassaemic children of age group of 2 years to 12 years. Int J Contemp Pediatr. 2019;6(4):1575-81.
Lokeshwar MR, Manglani M, Shaw N, Swathi Kanakia S. Modern trends in the management of Thalassemia. Indian J Pract Pediatr. 1997;5:287-96.
Choudhry VP, Desai N, Pati HP, Nanu A. Current Management of homozygous ß Thalassemia. Indian Paediatr. 1991;28(10):1221-9.
Shriharsha Badiger, Aditi Baruah. A study of growth pattern in regularly transfused thalassaemic children of age group of 2 years to 12 years. Int J Contemp Pediatr. 2019;6(4):1575-81.
Simhachalam M, Sahoo M, Kuppili U. A study on growth profiles in children with thalassemia major between 2-10 years of age on regular transfusions and oral chelation therapy. Int J Paediatr Res. 2018;5:78-87.
Ayoub MD, Radi SA, Azab AM, Abulaban AA, Balkhoyor AH, Bedair SE, et al. Quality of life among children with beta-thalassemia major treated in Western Saudi Arabia. Saudi Med J. 2013;34(12):1281-6.
Rathaur VK, Imran A, Pathania M. Growth pattern in thalassemic children and their correlation with serum ferritin. J Family Med Prim Care. 2020;9(2):1166-9.
Koreti S, Gaur BK, Das G, Gaur A. Study of Serum ferritin levels in β-Thalassemia major children. Int J Pediatr Res. 2018;5(6):308-13.
Neha D, Shekhar S, Akhouri MR. Observation on ECG changes in thalassemia major patients. IOSR J Dental Med Sci. 2016;15(7):28-31.
Shah N, Mishra A, Chauhan D, Vora C, Shah NR. Study on effectiveness of transfusion program in thalassemia major patients receiving multiple blood transfusions at a transfusion centre in Western India. Asian J Transf Sci. 2010;4(2):94-8.
Gomber S, Saxena R, Madan N. Comparative efficacy of desferrioxamine, deferiprone and in combination on iron chelation in thalessemic children. Indian Paed. 2004;41:21-6.
Shriharsha Badiger. A study of growth pattern in regularly transfused thalassaemic children of age group of 2 years to 12 years. 2019.
Bhat V, Dar MI, Digra SK, Sharma S. Impact of pretransfusion hemoglobin and ferritin levels on growth and clinical parameters in children with transfusion-dependent thalassemia major. J Scient Soc. 2025;52(3):283-9.
Huang YL, Liu S, Xia T. Relationship between growth disorders and iron overload in children with beta-Thalassemia major. Chin J Contemporary Pediatr. 2008;10(5):603-6.
Hashemi A, Ghilian R, Golestan M, Akhavan GM, Zare Z, Dehghani MA. The study of growth in thalassemic patients and its correlation with serum ferritin level. Iranian J Pediat Hematol Oncol. 2011;1(4):147.
Downloads
Published
How to Cite
Issue
Section
